Australias LNG Industry Warns Policy Uncertainty Is Hurting Investment XRP Ledgers May 27 Upgrade Draws Attention for Its Broader Potential Streaming Platforms Gear Up for Weekend Content Drop Netflix Hulu Prime Video Apple TV and More Unveil New Releases Meta Tests AI Subscription Plans Starting at 799 Monthly Signaling New Revenue Stream ReadytoDrink Cocktail Market Maintains Growth Momentum in 2026 Red Sox 55M Pitcher Faces Uncertain Future Amid Superstar Return DCH Q1 2026 Earnings Stunning EPS Beat Drives Strong Rally NVCR Q1 2026 Earnings WiderThanExpected Loss Fails to Dampen Investor Sentiment DCTH Q1 2026 Earnings NarrowerthanExpected Loss Signals Operational Progress GWAV Q3 2023 Earnings Significant EPS Loss Amidst Operational Challenges ARR Q1 2026 Earnings EPS Beats Estimates Amidst a Choppy Rate Environment Healthcare Services Group Inc HCSG Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Uptick Abundia Global Impact Group Surges Is AGIG Breaking Out from Consolidation Hims Hers Health HIMS Edges Higher Amid Steady Trading Key Levels in Focus International Money Express IMXI Holds Steady Near Support as Remittance Sector Faces Headwinds Tavia Acquisition Corp Unit TAVIU Edges Higher Amid Normal Trading Activity VKI Invesco Advantage Municipal Income Trust II Edges Higher as YieldSeeking Demand Persists Jim Cramer Advises Holding Astera Labs Shares Amid AI Infrastructure Growth INGR Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher Genco Shipping GNK Rides Positive Momentum Gaining 33 Amid Firming Dry Bulk Fundamentals BAC Q1 2026 Earnings Earnings Beat with 86 Surprise SON Q1 2026 Earnings EPS Slightly Misses Estimates Amid Mixed Market Signals CBSH Q1 2026 Earnings EPS Surpasses Expectations by 7 Amid Stable Operations Addex Therapeutics Q1 2024 Earnings PreRevenue Biotech Advances Pipeline Amid Narrowing Losses GLDG Q1 2026 Earnings Narrowerthanexpected loss as exploration ramp continues CIMN Q1 2026 Earnings EPS Beats Estimates by 282 MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline